Related references
Note: Only part of the references are listed.Factors to Consider in the Selection of Dopamine Agonists for Older Persons with Parkinson's Disease
Mark Dominic Latt et al.
DRUGS & AGING (2019)
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Klaus Seppi et al.
MOVEMENT DISORDERS (2019)
Randomized, double-blind, crossover study of the adhesiveness of two formulations of rotigotine transdermal patch in patients with Parkinson's disease
Jan-Peer Elshoff et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Dopamine agonist withdrawal syndrome: A comprehensive review
Xin Xin Yu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease
Santiago Perez-Lloret et al.
CNS DRUGS (2016)
A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists
A. Rizos et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2016)
Piribedil and Pathological Gambling in six Parkinsonian patients
Federico E. Micheli et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2015)
Role of Apomorphine in the Treatment of Parkinson's Disease
Allison Boyle et al.
CNS DRUGS (2015)
An Update on Pharmacological, Pharmacokinetic Properties and Drug-Drug Interactions of Rotigotine Transdermal System in Parkinson's Disease and Restless Legs Syndrome
Jan-Peer Elshoff et al.
DRUGS (2015)
Rotigotine Transdermal Patch Improves Swallowing in Dysphagic Patients with Parkinson's Disease
Makito Hirano et al.
DYSPHAGIA (2015)
Transdermal Dopamine Agonist Ameliorates Gastric Emptying in Parkinson's Disease
Hiromi Tateno et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Management of Impulse Control Disorders in Parkinson's Disease: Controversies and Future Approaches
Michael Samuel et al.
MOVEMENT DISORDERS (2015)
Role of Dopamine Neurons in Reward and Aversion: A Synaptic Plasticity Perspective
Marco Pignatelli et al.
NEURON (2015)
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations
Claudia Trenkwalder et al.
PARKINSONISM & RELATED DISORDERS (2015)
Parkinson's Disease Treatment May Cause Impulse-Control Disorder Via Dopamine D3 Receptors
Philip Seeman
SYNAPSE (2015)
Intravenous Administration of Apomorphine Does NOT Induce Long QT Syndrome: Experimental Evidence from In Vivo Canine Models
Yudai Watanabe et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2015)
Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: a post hoc analysis of the RECOVER study
Jan Kassubek et al.
BMC NEUROLOGY (2014)
Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
Santiago Perez-Lloret et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
Pedro J. Garcia-Ruiz et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease
Nir Giladi et al.
PARKINSONISM & RELATED DISORDERS (2014)
Dopamine Agonist Withdrawal Syndrome: Implications for Patient Care
Melissa J. Nirenberg
DRUGS & AGING (2013)
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease
Nir Giladi et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Acute genital pain during non-motor fluctuations improved by apomorphine
Romain Lefaucheur et al.
MOVEMENT DISORDERS (2013)
Prospective cohort study of impulse control disorders in Parkinson's disease
Jesse Bastiaens et al.
MOVEMENT DISORDERS (2013)
Rotigotine Transdermal Patch in Parkinson's Disease: A Systematic Review and Meta-Analysis
Chang-Qing Zhou et al.
PLOS ONE (2013)
Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease
Santiago Perez-Lloret et al.
CLINICAL NEUROPHARMACOLOGY (2012)
The Impact of Rotigotine on Cardiovascular Autonomic Function in Early Parkinson's Disease
Camilla Rocchi et al.
EUROPEAN NEUROLOGY (2012)
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: A prospective, open-label extension study
Lawrence W. Elmer et al.
PARKINSONISM & RELATED DISORDERS (2012)
Effect of rotigotine on sleep and quality of life in Parkinson's disease patients: post hoc analysis of RECOVER patients who were symptomatic at baseline
Liesbet Ghys et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Continuous dopaminergic stimulation and novel formulations of dopamine agonists
Fabrizio Stocchi
JOURNAL OF NEUROLOGY (2011)
Rotigotine Effects on Early Morning Motor Function and Sleep in Parkinson's Disease: A Double-Blind, Randomized, Placebo-Controlled Study (RECOVER)
Claudia Trenkwalder et al.
MOVEMENT DISORDERS (2011)
PREPARED: Comparison of Prolonged and Immediate Release Ropinirole in Advanced Parkinson's Disease
Fabrizio Stocchi et al.
MOVEMENT DISORDERS (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
Klaus Seppi et al.
MOVEMENT DISORDERS (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease
Susan H. Fox et al.
MOVEMENT DISORDERS (2011)
Extended-release pramipexole in early Parkinson disease A 33-week randomized controlled trial
W. Poewe et al.
NEUROLOGY (2011)
Extended-release pramipexole in advanced Parkinson disease A randomized controlled trial
A. H. V. Schapira et al.
NEUROLOGY (2011)
Drug Wanting: Behavioral Sensitization and Relapse to Drug-Seeking Behavior
Jeffery D. Steketee et al.
PHARMACOLOGICAL REVIEWS (2011)
Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Christina A. Rabinak et al.
ARCHIVES OF NEUROLOGY (2010)
Impulse Control Disorders in Parkinson Disease A Cross-Sectional Study of 3090 Patients
Daniel Weintraub et al.
ARCHIVES OF NEUROLOGY (2010)
Effects of Ropinirole Prolonged-Release on Sleep Disturbances and Daytime Sleepiness in Parkinson Disease
Petr Dusek et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Role of Pramipexole in the Management of Parkinson's Disease
Angelo Antonini et al.
CNS DRUGS (2010)
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Paolo Barone et al.
LANCET NEUROLOGY (2010)
Onset of Dyskinesia with Adjunct Ropinirole Prolonged-Release or Additional Levodopa in Early Parkinson's Disease
Ray L. Watts et al.
MOVEMENT DISORDERS (2010)
Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease
Jee-Young Lee et al.
PARKINSONISM & RELATED DISORDERS (2010)
Pharmacokinetics of a Once-Daily Extended-Release Formulation of Pramipexole in Healthy Male Volunteers: Three Studies
Peter Jenner et al.
CLINICAL THERAPEUTICS (2009)
Effects of Ropinirole on Nonmotor Symptoms of Parkinson Disease: A Prospective Multicenter Study
Irena Rektorova et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study
Fabrizio Stocchi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Dopamine agonists in Parkinson’s disease
Mitsutoshi Yamamoto et al.
Expert Review of Neurotherapeutics (2008)
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
Pedro J. Garcia Ruiz et al.
MOVEMENT DISORDERS (2008)
Ropinirole-induced symptomatic sinus node dysfunction
Catherine Szymanski et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2008)
Predictors of impulsivity and reward seeking behavior with dopamine agonists
William G. Ondo et al.
PARKINSONISM & RELATED DISORDERS (2008)
Apomorphine in the treatment of Parkinson's disease
Rukmini Menon et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Ropinirole 24-hour prolonged release - Randomized, controlled study in advanced Parkinson disease
R. Pahwa et al.
NEUROLOGY (2007)
Improvements in motor and non-motor symptoms in Parkinson patients under ropinirole therapy
B. Buchwald et al.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE (2007)
Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease
Ronald F. Pfeiffer et al.
PARKINSONISM & RELATED DISORDERS (2007)
Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease
Angelo Antonini et al.
LANCET NEUROLOGY (2007)
Correlation between striatal dopamine D2/D3 receptor binding and cardiovascular activity in healthy subjects
Tzung-Lieh Yeh et al.
AMERICAN JOURNAL OF HYPERTENSION (2006)
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists
Trond Kvernmo et al.
CLINICAL THERAPEUTICS (2006)
The mesolimbic dopamine reward circuit in depression
Eric J. Nestler et al.
BIOLOGICAL PSYCHIATRY (2006)
Review article:: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
M Tonini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats
JS Polakowski et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2004)
Subcutaneous apomorphine - An evidence-based review of its use in Parkinson's disease
D Deleu et al.
DRUGS & AGING (2004)
Dual dopamine agonist treatment in Parkinson's disease
F Stocchi et al.
JOURNAL OF NEUROLOGY (2003)
Pharmacology of dopamine agonists in the treatment of Parkinson's disease
P Jenner
NEUROLOGY (2002)
Dopamine, hypertension and obesity
F Contreras et al.
JOURNAL OF HUMAN HYPERTENSION (2002)
A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for Parkinsonian off-state events
RB Dewey et al.
ARCHIVES OF NEUROLOGY (2001)
Continuous dopamine-receptor stimulation in advanced Parkinson's disease
JG Nutt et al.
TRENDS IN NEUROSCIENCES (2000)
Clinical pharmacokinetics of ropinirole
CM Kaye et al.
CLINICAL PHARMACOKINETICS (2000)
Share Paper
